Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04739241Phase 4Completed
A Phase 4 trial of insulin lispro mix25, Insulin aspart + insulin aspart protamine in type 2 diabetes mellitus (T2DM), sponsored by Consorci Sanitari Integral. Started Jan 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04739241.